- 2024-08-20 02:10抑制剂Ro 08-2750|Ro 08-2750|37854-59-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Ro 08-2750|Ro 08-2750|37854-59-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RIPK1-IN-7|RIPK1-IN-7|2300982-44-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RN-18|RN-18|431980-38-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂RIPGBM|RIPGBM|355406-76-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂RIPGBM|RIPGBM|355406-76-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RIPK1-IN-7|RIPK1-IN-7|2300982-44-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂Rineterkib hydrochloride|Rineterkib hydrochloride|1715025-34-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Rineterkib hydrochloride|Rineterkib hydrochloride|1715025-34-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RIPGBM|RIPGBM|355406-76-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:10抑制剂Rimiducid|Rimiducid|195514-63-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Rimiducid|Rimiducid|195514-63-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Rineterkib hydrochloride|Rineterkib hydrochloride|1715025-34-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂Rilzabrutinib|Rilzabrutinib|1575596-29-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Rilzabrutinib|Rilzabrutinib|1575596-29-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Rimiducid|Rimiducid|195514-63-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂Ricolinostat|Ricolinostat|1316214-52-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:10抑制剂Ricolinostat|Ricolinostat|1316214-52-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Ricolinostat|Ricolinostat|1316214-52-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Rilzabrutinib|Rilzabrutinib|1575596-29-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
